• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

液相色谱-串联质谱法与夹心酶联免疫吸附测定法在血浆和尿液中硫酸角质素测定中的比较

Comparison of liquid chromatography-tandem mass spectrometry and sandwich ELISA for determination of keratan sulfate in plasma and urine.

作者信息

Hintze Jonathan P, Tomatsu Shunji, Fujii Tadashi, Montaño Adriana M, Yamaguchi Seiji, Suzuki Yasuyuki, Fukushi Masaru, Ishimaru Takeshi, Orii Tadao

机构信息

Department of Pediatrics, School of Medicine, Saint Louis University, St. Louis, MO, USA.

出版信息

Biomark Insights. 2011;6:69-78. doi: 10.4137/BMI.S7451. Epub 2011 Jun 27.

DOI:10.4137/BMI.S7451
PMID:21792275
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3140273/
Abstract

BACKGROUND AND AIM

Mucopolysaccharidosis IVA (MPS IVA) leads to skeletal dysplasia through excessive storage of chondroitin-6-sulfate and keratan sulfate (KS). KS is synthesized mainly in cartilage and released into circulation, making it a critical biomarker for MPS IVA to evaluate clinical course and effectiveness of therapies. Therefore, an accurate and sensitive method is required to measure KS levels.

MATERIAL AND METHODS

Using sandwich ELISA and liquid chromatography tandem mass spectrometry (LC/MS/MS) assays, we measured KS levels in blood and urine from MPS IVA patients and healthy controls to evaluate comparability of results. Blood (patients, n = 110; controls, n = 364) and urine (patients, n = 103; controls, n = 326) specimens were obtained.

RESULTS

Plasma and urine KS measurements in patients were age-dependent and higher than age-matched controls. We observed a moderate correlation (r = 0.666; P < 0.001) between urine KS measurements and a weak correlation (r = 0.333; P = 0.002) between plasma KS measurements by ELISA and LC/MS/MS methods in patients. No correlation was found between plasma KS measurements in controls. The difference between KS measurements assayed by LC/MS/MS and ELISA was greater in controls than in patients. A moderate correlation between blood and urine KS measurements in the same individual was observed.

CONCLUSION

These findings indicate that both methods to measure blood and urine KS are suitable for diagnosis, monitoring therapies, and longitudinal assessment of the disease course in MPS IVA, but the LC/MS/MS method measures over 10 times more KS present in body fluids.

摘要

背景与目的

IVA型黏多糖贮积症(MPS IVA)通过硫酸软骨素-6-硫酸盐和硫酸角质素(KS)的过度蓄积导致骨骼发育异常。KS主要在软骨中合成并释放到循环系统中,使其成为评估MPS IVA临床病程和治疗效果的关键生物标志物。因此,需要一种准确且灵敏的方法来测量KS水平。

材料与方法

我们使用夹心酶联免疫吸附测定法(ELISA)和液相色谱串联质谱法(LC/MS/MS),测量了MPS IVA患者和健康对照者血液和尿液中的KS水平,以评估结果的可比性。采集了血液(患者110例;对照364例)和尿液(患者103例;对照326例)样本。

结果

患者血浆和尿液中的KS测量值与年龄相关,且高于年龄匹配的对照者。我们观察到患者尿液KS测量值之间存在中度相关性(r = 0.666;P < 0.001),而ELISA法和LC/MS/MS法测量患者血浆KS值之间存在弱相关性(r = 0.333;P = 0.002)。对照者血浆KS测量值之间未发现相关性。LC/MS/MS法和ELISA法测量对照者KS值的差异大于患者。在同一个体中观察到血液和尿液KS测量值之间存在中度相关性。

结论

这些发现表明,测量血液和尿液KS的两种方法均适用于MPS IVA的诊断、治疗监测和疾病病程的纵向评估,但LC/MS/MS法测量的体液中KS含量是另一种方法的10倍以上。

相似文献

1
Comparison of liquid chromatography-tandem mass spectrometry and sandwich ELISA for determination of keratan sulfate in plasma and urine.液相色谱-串联质谱法与夹心酶联免疫吸附测定法在血浆和尿液中硫酸角质素测定中的比较
Biomark Insights. 2011;6:69-78. doi: 10.4137/BMI.S7451. Epub 2011 Jun 27.
2
Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry.通过液相色谱-串联质谱法对黏多糖贮积症 IVA 型中硫酸角质素水平的验证。
J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S35-42. doi: 10.1007/s10545-009-9013-x. Epub 2010 Jan 27.
3
Glycosaminoglycans analysis in blood and urine of patients with mucopolysaccharidosis.糖胺聚糖分析在黏多糖贮积症患者的血液和尿液。
Mol Genet Metab. 2018 Sep;125(1-2):44-52. doi: 10.1016/j.ymgme.2018.04.011. Epub 2018 May 17.
4
Development and testing of new screening method for keratan sulfate in mucopolysaccharidosis IVA.黏多糖贮积症IVA中硫酸角质素新筛查方法的开发与测试
Pediatr Res. 2004 Apr;55(4):592-7. doi: 10.1203/01.PDR.0000113767.60140.E9. Epub 2004 Jan 7.
5
Mucopolysaccharidosis IVA: correlation between genotype, phenotype and keratan sulfate levels.黏多糖贮积症 IVA:基因型、表型与硫酸角质素水平的相关性。
Mol Genet Metab. 2013 Sep-Oct;110(1-2):129-38. doi: 10.1016/j.ymgme.2013.06.008. Epub 2013 Jun 26.
6
Di-sulfated Keratan Sulfate as a Novel Biomarker for Mucopolysaccharidosis II, IVA, and IVB.二硫酸角质素作为黏多糖贮积症II型、IVA 型和IVB型的新型生物标志物
JIMD Rep. 2015;21:1-13. doi: 10.1007/8904_2014_330. Epub 2015 Feb 25.
7
Measurement of Elevated Concentrations of Urine Keratan Sulfate by UPLC-MSMS in Lysosomal Storage Disorders (LSDs): Comparison of Urine Keratan Sulfate Levels in MPS IVA Versus Other LSDs.采用超高效液相色谱-串联质谱法(UPLC-MSMS)测定溶酶体贮积症(LSDs)患者尿液中硫酸角质素的升高浓度:IV型黏多糖贮积症(MPS IVA)与其他LSDs患者尿液中硫酸角质素水平的比较。
JIMD Rep. 2017;34:11-18. doi: 10.1007/8904_2016_1. Epub 2016 Jul 28.
8
Chondroitin 6-Sulfate as a Novel Biomarker for Mucopolysaccharidosis IVA and VII.硫酸软骨素6-硫酸盐作为黏多糖贮积症IVA和VII的新型生物标志物
JIMD Rep. 2014;16:15-24. doi: 10.1007/8904_2014_311. Epub 2014 May 22.
9
Chondroitin sulfate disaccharide is a specific and sensitive biomarker for mucopolysaccharidosis type IVA.硫酸软骨素二糖是IVA型黏多糖贮积症的一种特异性且敏感的生物标志物。
JIMD Rep. 2020 Jun 30;55(1):68-74. doi: 10.1002/jmd2.12132. eCollection 2020 Sep.
10
Validation of an LC-MS/MS assay for detecting relevant disaccharides from keratan sulfate as a biomarker for Morquio A syndrome.用于检测来自硫酸角质素的相关二糖作为黏多糖贮积症IVA型综合征生物标志物的液相色谱-串联质谱法检测的验证。
Bioanalysis. 2011 Aug;3(16):1855-66. doi: 10.4155/bio.11.172.

引用本文的文献

1
direct lentiviral gene therapy improves disease pathology in a mucopolysaccharidosis IVA murine model.直接慢病毒基因疗法改善了黏多糖贮积症IVA小鼠模型中的疾病病理。
Mol Ther Methods Clin Dev. 2025 Jun 16;33(3):101514. doi: 10.1016/j.omtm.2025.101514. eCollection 2025 Sep 11.
2
Assessment of different promoters in lentiviral vectors for expression of the N-acetyl-galactosamine-6-sulfate sulfatase gene.慢病毒载体中不同启动子用于N-乙酰半乳糖胺-6-硫酸酯硫酸酯酶基因表达的评估
J Hum Genet. 2025 Jun 10. doi: 10.1038/s10038-025-01353-x.
3
Identification of Surrogate Biomarkers for Mucopolysaccharidosis Type IVA.

本文引用的文献

1
Mucopolysaccharidosis type IVA (Morquio A disease): clinical review and current treatment.黏多糖贮积症 IVA 型(莫尔奎奥 A 病):临床综述与当前治疗。
Curr Pharm Biotechnol. 2011 Jun;12(6):931-45. doi: 10.2174/138920111795542615.
2
Adeno-associated virus gene transfer in Morquio A disease - effect of promoters and sulfatase-modifying factor 1.腺相关病毒基因转移在莫氏病 A 型中的作用 - 启动子和硫酸酯酶修饰因子 1 的影响。
FEBS J. 2010 Sep;277(17):3608-19. doi: 10.1111/j.1742-4658.2010.07769.x.
3
Enhancement of drug delivery: enzyme-replacement therapy for murine Morquio A syndrome.
IVA型黏多糖贮积症替代生物标志物的鉴定
Int J Mol Sci. 2025 May 21;26(10):4940. doi: 10.3390/ijms26104940.
4
Evaluation of AAV vectors with tissue-specific or ubiquitous promoters in a mouse model of mucopolysaccharidosis type IVA.在IVA型黏多糖贮积症小鼠模型中对具有组织特异性或普遍启动子的腺相关病毒载体进行评估。
Mol Ther Methods Clin Dev. 2025 Mar 14;33(2):101447. doi: 10.1016/j.omtm.2025.101447. eCollection 2025 Jun 12.
5
Lentiviral Vector-Mediated Hematopoietic Stem Cell Gene Therapy for Mucopolysaccharidosis IVA Murine Model.慢病毒载体介导的造血干细胞基因治疗黏多糖贮积症 IVA 小鼠模型。
Hum Gene Ther. 2024 Nov;35(21-22):917-937. doi: 10.1089/hum.2024.094. Epub 2024 Oct 24.
6
Detection of Glycosaminoglycans in Biological Specimens.生物标本中糖胺聚糖的检测。
Methods Mol Biol. 2023;2619:3-24. doi: 10.1007/978-1-0716-2946-8_1.
7
Mucopolysaccharidosis Type IVA: Extracellular Matrix Biomarkers in Cardiovascular Disease.IVA型黏多糖贮积症:心血管疾病中的细胞外基质生物标志物
Front Cardiovasc Med. 2022 May 10;9:829111. doi: 10.3389/fcvm.2022.829111. eCollection 2022.
8
Activity of daily living in mucopolysaccharidosis IVA patients: Evaluation of therapeutic efficacy.黏多糖贮积症 IVA 患者的日常生活活动能力:疗效评估。
Mol Genet Genomic Med. 2021 Nov;9(11):e1806. doi: 10.1002/mgg3.1806. Epub 2021 Oct 8.
9
Diagnosis of Mucopolysaccharidoses and Mucolipidosis by Assaying Multiplex Enzymes and Glycosaminoglycans.通过检测多种酶和糖胺聚糖诊断黏多糖贮积症和黏脂贮积症
Diagnostics (Basel). 2021 Jul 27;11(8):1347. doi: 10.3390/diagnostics11081347.
10
A 9-Month-Old with Skeletal Abnormalities and a Consanguineous Sibling with Mucopolysaccharidosis IVA: The Role of Urinary Glycosaminoglycan Testing in Disease Diagnosis and Treatment Monitoring.一名患有骨骼异常的9个月大婴儿及一名患有IVA型黏多糖贮积症的近亲同胞:尿糖胺聚糖检测在疾病诊断和治疗监测中的作用
Clin Med Insights Case Rep. 2021 Mar 6;14:1179547621999409. doi: 10.1177/1179547621999409. eCollection 2021.
增强药物传递:用于治疗鼠类黏多糖贮积症 A 型的酶替代疗法。
Mol Ther. 2010 Jun;18(6):1094-102. doi: 10.1038/mt.2010.32. Epub 2010 Mar 23.
4
Validation of keratan sulfate level in mucopolysaccharidosis type IVA by liquid chromatography-tandem mass spectrometry.通过液相色谱-串联质谱法对黏多糖贮积症 IVA 型中硫酸角质素水平的验证。
J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S35-42. doi: 10.1007/s10545-009-9013-x. Epub 2010 Jan 27.
5
Sacral dimple: incidental findings from newborn evaluation. Mucopolysaccharidosis IVA disease.骶部酒窝:新生儿评估中的偶然发现。黏多糖贮积症IVA型疾病。
Acta Paediatr. 2009 May;98(5):768-9, 910-2. doi: 10.1111/j.1651-2227.2009.01134.x.
6
Growth charts for patients affected with Morquio A disease.患有莫尔基奥A综合征患者的生长图表。
Am J Med Genet A. 2008 May 15;146A(10):1286-95. doi: 10.1002/ajmg.a.32281.
7
Enzyme replacement therapy in a murine model of Morquio A syndrome.在莫尔基奥A综合征小鼠模型中的酶替代疗法。
Hum Mol Genet. 2008 Mar 15;17(6):815-24. doi: 10.1093/hmg/ddm353. Epub 2007 Dec 3.
8
International Morquio A Registry: clinical manifestation and natural course of Morquio A disease.国际莫尔基奥A综合征注册库:莫尔基奥A病的临床表现和自然病程
J Inherit Metab Dis. 2007 Apr;30(2):165-74. doi: 10.1007/s10545-007-0529-7. Epub 2007 Mar 8.
9
Analytical method for determination of disaccharides derived from keratan sulfates in human serum and plasma by high-performance liquid chromatography/turbo-ionspray ionization tandem mass spectrometry.高效液相色谱/涡轮离子喷雾电离串联质谱法测定人血清和血浆中硫酸角质素衍生二糖的分析方法
Biomed Chromatogr. 2007 Apr;21(4):356-62. doi: 10.1002/bmc.760.
10
The structure and function of cartilage proteoglycans.软骨蛋白聚糖的结构与功能。
Eur Cell Mater. 2006 Nov 30;12:92-101. doi: 10.22203/ecm.v012a11.